Related Experiment Videos

Vasoconstrictor activity of coronary sinus plasma from patients with coronary artery disease

Insights

Plasma from the coronary sinus of patients with coronary artery disease causes vasoconstriction, potentially linked to serotonin release from platelets. This effect correlates with the severity of coronary artery narrowing.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Coronary artery disease (CAD) involves complex pathophysiological changes.
  • Understanding the vasoactive properties of blood in CAD is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the vasoactive properties of plasma from different circulatory sources in patients with CAD.
  • To identify potential mediators of vasoconstriction in the coronary sinus blood of CAD patients.

Main Methods:

  • In vitro bioassay using isolated canine coronary artery rings.
  • Measurement of tension changes in response to plasma samples from systemic arteries, superior vena cava, and coronary sinus.
  • Assessment of plasma from patients with and without CAD, under rest and exercise conditions.
  • Pharmacological blockade using a serotoninergic receptor antagonist.

Main Results:

  • Coronary sinus plasma from CAD patients induced relaxation followed by constriction in arteries with endothelium, and only constriction in arteries without endothelium.
  • Vasoconstrictor activity in coronary sinus plasma positively correlated with the severity and extent of coronary artery narrowing.
  • Plasma from systemic circulation and coronary sinus plasma from non-CAD patients induced only endothelium-dependent relaxations.
  • Methiothepin blocked the vasoconstriction, suggesting a role for serotonin (5-hydroxytryptamine).

Conclusions:

  • Coronary sinus blood in patients with atheromatous CAD exhibits vasoconstrictor activity.
  • This activity is likely mediated by platelet-released serotonin (5-hydroxytryptamine).
  • The findings suggest a potential mechanism contributing to altered coronary blood flow in CAD.

Related Concept Videos